Trialect

Active

DO NOT APPLY Colorectal Cancer and Inflammatory Bowel Disease

Xue Lab, The University of New Mexico

Dr. Xiang Xue’s lab at the University of New Mexico focuses on understanding the molecular mechanisms underlying inflammatory bowel disease (IBD) and colorectal cancer (CRC). His research integrates cell line and enteroid cultures, mouse models, patient tissues, and a wide array of molecular and biochemical methodologies to uncover critical pathways that drive disease progression.

This fellowship will provide hands-on training and theoretical insights into key research areas, including:

The Role of Micronutrients in Cancer Cell Growth – How essential nutrients regulate tumor progression.
Mitochondrial Metabolism and Cancer – The impact of metabolic reprogramming on tumor survival.
Stress-Activated Pathways in Cancer Metabolism – Understanding cellular stress responses in tumor growth.
Hypoxia Signaling in Intestinal Inflammation and CRC – The influence of HIF pathways on disease progression.
Nutrient Homeostasis, Inflammation, and Cancer – How metabolic imbalance links to chronic inflammation and cancer initiation.

Participants will gain expertise in iron metabolism, hypoxia biology, oxidative stress, and mitochondrial dysfunction, using state-of-the-art techniques such as organoid culture, metabolomics, CRISPR gene editing, and advanced imaging to explore novel therapeutic strategies for gastrointestinal diseases.

Main Areas of Interest

Iron Metabolism & Nutrient Regulation in CRC & IBD

How iron homeostasis, micronutrients, and metabolic pathways drive cancer progression and inflammation.
Role of DMT1, hepcidin, and transferrin receptor in colon tumorigenesis.
Link between nutrient metabolism and immune response in IBD.

Hypoxia & Inflammatory Signaling in CRC & IBD

Role of Hypoxia-Inducible Factors (HIF-1α, HIF-2α) in gut inflammation and tumor growth.
How oxygen deprivation in the gut microenvironment affects IBD severity and CRC progression.
Targeting hypoxia pathways for therapeutic interventions in gastrointestinal diseases.

Mitochondrial Dysfunction & Oxidative Stress in CRC & IBD

How mitochondrial stress and mitophagy (PINK1, Sestrin2) regulate tumorigenesis.
Reactive oxygen species (ROS) & inflammation in CRC and IBD.
Exploring mitochondrial-targeted therapies for colorectal cancer treatment.

Immune System & Microbiome in CRC & IBD

Role of immune cells (T-cells, macrophages, neutrophils) and cytokines in colitis and cancer progression.
Influence of gut microbiome dysbiosis on CRC and IBD pathogenesis.
Using immune modulation & microbiome-based therapies for disease management.

Specialties

Oncology

Cancer

Gastroenterology

Techniques You Will Learn

Techniques You Can Learn

Participants will gain experience with the following molecular, cellular, and computational techniques:

Molecular Biology & Gene Regulation

qPCR, Western Blot, Immunohistochemistry (IHC), ELISA
CRISPR-Cas9 gene editing
RNA sequencing (RNA-seq) & transcriptomics

Hypoxia & Oxidative Stress Assays

HIF activation assays
ROS detection (DCFDA staining)
Seahorse metabolic flux analysis

Cell & Organoid Models for CRC & IBD

2D and 3D enteroid and colonoid cultures
In vitro tumor spheroids & organoid drug screening

Animal Models & In Vivo Research

Mouse models for CRC & IBD (colitis, DSS, AOM models)
Iron metabolism studies in mice

Microbiome & Immunology Assays

Flow cytometry for immune profiling
Cytokine multiplex assays
Gut microbiome sequencing (16S rRNA analysis)

Curriculum

Can be customized based on the visiting scientist needs

12-Week General Fellowship Curriculum

Week 1: Orientation & Access

The program begins with an orientation session, where participants will gain access to research facilities, lab protocols, and safety guidelines. They will be introduced to the research team, their mentorship structure, and available resources, including databases, lab equipment, and experimental models used in colorectal cancer (CRC) and inflammatory bowel disease (IBD) research.

Week 2: Review of Basics

Participants will conduct an in-depth literature review on CRC and IBD pathogenesis, focusing on key molecular pathways, recent advances, and unresolved research questions. They will analyze landmark studies, discuss research gaps, and attend expert-led sessions on nutrient metabolism, hypoxia signaling, and immune responses in gastrointestinal diseases.

Accommodation

Try airbnb.com

Fees and Program Logistics

This program has the following durations available:

Duration	Total Fee
6 weeks	$1,575.00
12 weeks	$2,725.00

This program allows Merit Applications. This program allows merit-based applications for virtual and onsite clinical and research programs. If you are successfully awarded under this category, Trialect or the host mentor will cover the tuition fee only. All applications will be evaluated based on merit. Due to the high level of competition, the chances of being selected under the merit category are quite limited.

Who Can Apply

Life Sciences and Health care

Host Details

Host Name: Xiang Xue

Affiliation: Xue Lab, The University of New Mexico

Address: MSC 08 4670, Fitz Hall 259, 915 Camino de Salud NE, Albuquerque, NM 87131

Website URL: https://sites.google.com/site/xiangxueus/home?authuser=0

Disclaimer:It is mandatory that all applicants carry workplace liability insurance, e.g., https://www.protrip-world-liability.com (Erasmus students use this package and typically costs around 5 € per month - please check) in addition to health insurance when you join any of the onsite Trialect partnered fellowships.

Legal & Affiliation Disclaimer

Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.

Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.

Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.

Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.

Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.

Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.

Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.